Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter; Toni Weinschenk; Arnulf Stenzl; Romuald Zdrojowy; A Płużańska; Cezary Szczylik; Michael Staehler; Wolfram Brugger; Pierre-Yves Dietrich; Regina Mendrzyk; Norbert Hilf; Oliver Schoor; Jens Fritsche; Andrea Mahr; Dominik Maurer; Verona Vass; Claudia Trautwein; Peter Lewandrowski; Christian Flohr; Heike Pohla; Janusz J Stańczak; Vincenzo Bronte; Susanna Mandruzzato; Tilo Biedermann; Graham Pawelec; Evelyna Derhovanessian; Hisakazu Yamagishi; Tsuneharu Miki; Fumiya Hongo; Natsuki Takaha; Kosei Hirakawa; Hiroaki Tanaka; Stefan Stevanović; Jürgen Frisch; Andrea Mayer-Mokler; Alexandra Kirner; Hans-Georg Rammensee; Carsten Reinhardt; Harpreet Singh‐Jasuja

doi:10.1038/nm.2883

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter(Immatics Biotechnologies (Germany)), Toni Weinschenk(Immatics Biotechnologies (Germany)), Arnulf Stenzl(University of Tübingen), Romuald Zdrojowy, A Płużańska, Cezary Szczylik(Wojskowy Instytut Medycyny Lotniczej), Michael Staehler(Ludwig-Maximilians-Universität München), Wolfram Brugger(Schwarzwald-Baar Klinikum), Pierre-Yves Dietrich(University Hospital of Geneva), Regina Mendrzyk(Immatics Biotechnologies (Germany)), Norbert Hilf(Immatics Biotechnologies (Germany)), Oliver Schoor(Immatics Biotechnologies (Germany)), Jens Fritsche(Immatics Biotechnologies (Germany)), Andrea Mahr(Immatics Biotechnologies (Germany)), Dominik Maurer(Immatics Biotechnologies (Germany)), Verona Vass(Immatics Biotechnologies (Germany)), Claudia Trautwein(Immatics Biotechnologies (Germany)), Peter Lewandrowski(Immatics Biotechnologies (Germany)), Christian Flohr(Immatics Biotechnologies (Germany)), Heike Pohla(Helmholtz Zentrum München), Janusz J Stańczak, Vincenzo Bronte(University of Verona), Susanna Mandruzzato(University of Padua), Tilo Biedermann(University of Tübingen), Graham Pawelec(University of Tübingen), Evelyna Derhovanessian(University of Tübingen), Hisakazu Yamagishi(Kyoto Prefectural University of Medicine), Tsuneharu Miki(Kyoto Prefectural University of Medicine), Fumiya Hongo(Kyoto Prefectural University of Medicine), Natsuki Takaha(Kyoto Prefectural University of Medicine), Kosei Hirakawa(Osaka City University), Hiroaki Tanaka(Osaka City University), Stefan Stevanović(University of Tübingen), Jürgen Frisch(Immatics Biotechnologies (Germany)), Andrea Mayer-Mokler(Immatics Biotechnologies (Germany)), Alexandra Kirner(Immatics Biotechnologies (Germany)), Hans-Georg Rammensee(University of Tübingen), Carsten Reinhardt(Immatics Biotechnologies (Germany)), Harpreet Singh‐Jasuja(Immatics Biotechnologies (Germany))

Nature Medicine

July 29, 2012

10.1038/nm.2883

Cited by 782Open Access

Full Text